Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Folini

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|June 2, 2021
On the Road to Fight Cancer: The Potential of G-quadruplex Ligands as Novel Therapeutic AgentsIrene Alessandrini, Marta Recagni, Nadia Zaffaroni, et al.
Expert Opinion on Therapeutic Targets|January 7, 2011
MicroRNAs as new therapeutic targets and tools in cancerPaolo Gandellini, Valentina Profumo, Marco Folini, et al.
Cancers|April 16, 2020
The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic ImplicationsMarta Recagni, Joanna Bidzinska, Nadia Zaffaroni, et al.
Current Drug Targets|March 18, 2015
MicroRNAs and the Response of Prostate Cancer to Anti-Cancer DrugsMarzia Pennati, Marco Folini, Paolo Gandellini, et al.
Expert Opinion on Therapeutic Targets|February 4, 2011
Telomeres as targets for anticancer therapiesMarco Folini, Lorenza Venturini, Graziella Cimino-Reale, et al.
Molecules (Basel, Switzerland)|October 11, 2013
G-quadruplex structures in the human genome as novel therapeutic targetsJoanna Bidzinska, Graziella Cimino-Reale, Nadia Zaffaroni, et al.
Current Topics in Medicinal Chemistry|December 27, 2011
RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapyMarzia Pennati, Enrico Millo, Paolo Gandellini, et al.
Current Pharmaceutical Design|July 1, 2014
MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promisingFrancesca Santambrogio, Paolo Gandellini, Graziella Cimino-Reale, et al.
Oncotarget|February 27, 2016
miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cellsElisabetta Crippa, Marco Folini, Marzia Pennati, et al.
Organic & Biomolecular Chemistry|November 8, 2014
Naphthalene diimides as red fluorescent pH sensors for functional cell imagingFilippo Doria, Marco Folini, Vincenzo Grande, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|June 2, 2021
On the Road to Fight Cancer: The Potential of G-quadruplex Ligands as Novel Therapeutic AgentsIrene Alessandrini, Marta Recagni, Nadia Zaffaroni, et al.
Expert Opinion on Therapeutic Targets|January 7, 2011
MicroRNAs as new therapeutic targets and tools in cancerPaolo Gandellini, Valentina Profumo, Marco Folini, et al.
Cancers|April 16, 2020
The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic ImplicationsMarta Recagni, Joanna Bidzinska, Nadia Zaffaroni, et al.
Current Drug Targets|March 18, 2015
MicroRNAs and the Response of Prostate Cancer to Anti-Cancer DrugsMarzia Pennati, Marco Folini, Paolo Gandellini, et al.
Expert Opinion on Therapeutic Targets|February 4, 2011
Telomeres as targets for anticancer therapiesMarco Folini, Lorenza Venturini, Graziella Cimino-Reale, et al.
Molecules (Basel, Switzerland)|October 11, 2013
G-quadruplex structures in the human genome as novel therapeutic targetsJoanna Bidzinska, Graziella Cimino-Reale, Nadia Zaffaroni, et al.
Current Topics in Medicinal Chemistry|December 27, 2011
RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapyMarzia Pennati, Enrico Millo, Paolo Gandellini, et al.
Current Pharmaceutical Design|July 1, 2014
MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promisingFrancesca Santambrogio, Paolo Gandellini, Graziella Cimino-Reale, et al.
Oncotarget|February 27, 2016
miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cellsElisabetta Crippa, Marco Folini, Marzia Pennati, et al.
Organic & Biomolecular Chemistry|November 8, 2014
Naphthalene diimides as red fluorescent pH sensors for functional cell imagingFilippo Doria, Marco Folini, Vincenzo Grande, et al.
Pageof 7